Dr. Cognetti is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
925 Chestnut St
Philadelphia, PA 19107Phone+1 215-955-6760Fax+1 215-923-4532
Summary
- David M. Cognetti, MD is the Herbert Kean, MD Professor and Chair of the Department of Otolaryngology – Head and Neck Surgery at the Sidney Kimmel Medical College/Sidney Kimmel Cancer Center at Thomas Jefferson University in Philadelphia, PA.
Education & Training
- UPMC Medical EducationFellowship, Head & Neck Surgical Oncology/Microvascular Reconstruction, 2007 - 2008
- Sidney Kimmel Medical College at Thomas Jefferson University/TJUHResidency, Otolaryngology - Head and Neck Surgery, 2002 - 2007
- Sidney Kimmel Medical College at Thomas Jefferson UniversityInternship, Transitional Year, 2002 - 2003
- University of Pittsburgh School of MedicineClass of 2002
Certifications & Licensure
- NJ State Medical License 2021 - 2025
- PA State Medical License 2002 - 2024
- American Board of Otolaryngology - Head and Neck Surgery Otolaryngology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification Allscripts Enterprise EHR, Allscripts, 2012-2013
- Fellow (FACS) American College of Surgeons
Clinical Trials
- The Effect of Sodium Thiosulfate Eardrops on Hearing Loss in Patients Who Receive Cisplatin Therapy Start of enrollment: 2011 Aug 24
- Measuring Biomarker Response to AMP-514 in Blood Samples From Patients With Solid Tumors Undergoing Radiotherapy Start of enrollment: 2013 Nov 11
- Circulating Tumor DNA in Predicting Outcomes in Patients With Stage IV Head and Neck Cancer or Stage III-IV Non-small Cell Lung Cancer Start of enrollment: 2014 Jul 22
Publications & Presentations
PubMed
- 154 citationsHead and neck cancer: an evolving treatment paradigm.David Cognetti, Randal S. Weber, Stephen Y. Lai
Cancer. 2008-10-01 - 26 citationsTadalafil Enhances Immune Signatures in Response to Neoadjuvant Nivolumab in Resectable Head and Neck Squamous Cell Carcinoma.Adam J Luginbuhl, Jennifer M Johnson, Larry A Harshyne, Alban J Linnenbach, Sanket K Shukla
Clinical Cancer Research. 2022-03-01 - 9 citationsCervical Spine Spondylodiscitis After Esophageal Dilation in Patients With a History of Laryngectomy or Pharyngectomy and Pharyngeal Irradiation.Jill N. D’Souza, Adam Luginbuhl, Richard A. Goldman, Joshua Heller, Joseph Curry
JAMA Otolaryngology-- Head & Neck Surgery. 2016-05-01
Journal Articles
- Association of Positive Initial Margins with Survival Among Patients with Squamous Cell Carcinoma Treated with Total LaryngectomyCorey Savard, David Cognetti, Michael C Topf, William Keane, Joseph Curry, Patrick Tassone, Adam Luginbuhl, JAMA
Authored Content
- AAO-HNSF 2022: Forward Together and Back TogetherSeptember 2022
Press Mentions
- A Remarkable Year in Foundation EducationSeptember 2nd, 2024
- Doctors Say There’s an Alarming Increase in Oral Cancer Due to HPVMay 3rd, 2017
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: